An Analysis of the Relationship Between Preclinical and Clinical QT Interval-Related Data-Reference-Cited by-同舟云学术

An Analysis of the Relationship Between Preclinical and Clinical QT Interval-Related Data

Published:2017-06-16 Issue:1 Volume:159 Page:94-101
ISSN:1096-6080
Container-title:Toxicological Sciences
language:en
Short-container-title:

Author:

Pollard Christopher E.,Skinner Matthew,Lazic Stanley E.,Prior Helen M.,Conlon Kelly M.,Valentin Jean-Pierre,Dota Corina

Publisher

Oxford University Press (OUP)

Subject

Toxicology

Link

http://academic.oup.com/toxsci/article-pdf/159/1/94/19636651/kfx125.pdf

Reference20 articles.

1. International Conference on Harmonisation; guidance on S7a Safety Pharmacology Studies for Human Pharmaceuticals;Anonymous;Notice Fed. Regist,2001

2. International Conference on Harmonisation; guidance on S7b Nonclinical evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals; availability;Anonymous;Notice Fed. Regist.,2005

3. International Conference on Harmonisation; guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs; availability;Anonymous;Notice Fed Regist,2005

4. Diagnostic tests 1: sensitivity and specificity;Br. Med. J,1994

5. Diagnostic tests 2: predictive values;Br. Med. J,1994

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Semisynthetic guanidino lipoglycopeptides with potent in vitro and in vivo antibacterial activity;Science Translational Medicine;2024-08-07

2. Supporting an integrated QTc risk assessment using the hERG margin distributions for three positive control agents derived from multiple laboratories and on multiple occasions.;Journal of Pharmacological and Toxicological Methods;2024-07

3. Results from a Joined Prospective Study to Evaluate the Sensitivity of the In Vivo Dog QT Assay in Line with the ICH E14/S7B Q&A Best Practices;Clinical Pharmacology & Therapeutics;2024-05-06

4. Overview of the ICH E14/S7B: Questions and Answers;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2024

5. Systematical Evaluation of the Structure-Cardiotoxicity Relationship of 7-Azaindazole-based PI3K Inhibitors Designed by Bioisosteric Approach;Cardiovascular Toxicology;2023-10-03